These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 11823451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease.
    Ivanchuk SM, Myers SM, Eng C, Mulligan LM.
    Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease.
    Doray B, Salomon R, Amiel J, Pelet A, Touraine R, Billaud M, Attié T, Bachy B, Munnich A, Lyonnet S.
    Hum Mol Genet; 1998 Sep; 7(9):1449-52. PubMed ID: 9700200
    [Abstract] [Full Text] [Related]

  • 9. Mutational analysis of RET/GDNF/NTN genes in children with total colonic aganglionosis with small bowel involvement.
    Inoue K, Shimotake T, Iwai N.
    Am J Med Genet; 2000 Aug 14; 93(4):278-84. PubMed ID: 10946353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.
    Gath R, Goessling A, Keller KM, Koletzko S, Coerdt W, Müntefering H, Wirth S, Hofstra RM, Mulligan L, Eng C, von Deimling A.
    Gut; 2001 May 14; 48(5):671-5. PubMed ID: 11302967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
    Geneste O, Bidaud C, De Vita G, Hofstra RM, Tartare-Deckert S, Buys CH, Lenoir GM, Santoro M, Billaud M.
    Hum Mol Genet; 1999 Oct 14; 8(11):1989-99. PubMed ID: 10484767
    [Abstract] [Full Text] [Related]

  • 16. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.
    Mograbi B, Bocciardi R, Bourget I, Juhel T, Farahi-Far D, Romeo G, Ceccherini I, Rossi B.
    Mol Cell Biol; 2001 Oct 14; 21(20):6719-30. PubMed ID: 11564857
    [Abstract] [Full Text] [Related]

  • 17. Glial cell line-derived neurotrophic factor family receptors are abnormally expressed in aganglionic bowel of a subpopulation of patients with Hirschsprung's disease.
    Lui VC, Samy ET, Sham MH, Mulligan LM, Tam PK.
    Lab Invest; 2002 Jun 14; 82(6):703-12. PubMed ID: 12065680
    [Abstract] [Full Text] [Related]

  • 18. The GDNF-RET signalling partnership.
    Robertson K, Mason I.
    Trends Genet; 1997 Jan 14; 13(1):1-3. PubMed ID: 9009838
    [No Abstract] [Full Text] [Related]

  • 19. Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex.
    Eketjäll S, Fainzilber M, Murray-Rust J, Ibáñez CF.
    EMBO J; 1999 Nov 01; 18(21):5901-10. PubMed ID: 10545102
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.